Wednesday, October 12, 2005

NIAID launches first Phase II trial of a 'global' HIV/AIDS vaccine

NIAID launches first Phase II trial of a 'global' HIV/AIDS vaccine:
"A novel vaccine targeted to multiple HIV subtypes found worldwide has moved into the second phase of clinical testing, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today."

I always like to hear of some good news here and there. A little hope can go a long way.
Post a Comment

Followers

Blog Archive